Apoptosis Induction and Cell Cycle Profiling after Treatment with Low-Dose Decitabine and/or Bortezomib in the AML Cell Line Kasumi-1

被引：0
|
作者：
Mpakou, Vassiliki
Spathis, Aris
Velentzas, Athanassios
Kontsioti, Frieda
Bouhla, Anthi
Gkodopoulos, Konstantinos
Stavroulaki, Georgia
Glezou, Irene
Papageorgiou, Sotirios
Bazani, Efthimia
Vasilatou, Diamantina
Symeonidis, Argiris
Dimitriadis, George
Pappa, Vassiliki
机构：
来源：
BLOOD | 2017年 / 130卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4994
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Synergistic inhibitory effects of low-dose decitabine in combination with bortezomib in the AML cell line Kasumi-1
    Mpakou, Vassiliki
    Spathis, Aris
    Bouhla, Anthi
    Mpazani, Efthimia
    Papageorgiou, Sotirios
    Gkontopoulos, Konstantinos
    Glezou, Eirini
    Thomopoulos, Thomas
    Foukas, Periklis
    Pappa, Vasiliki
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2021, 21 (03)
  • [2] Transcription of the AML1/ETO chimera is guided by the P2 promoter of the AML1 gene in the Kasumi-1 cell line
    Markova, Elena N.
    Kantidze, Omar L.
    Razin, Sergey V.
    GENE, 2012, 510 (02) : 142 - 146
  • [3] Efficacy of Low-Dose Decitabine in the Early Relapse of AML/MDS after Allogeneic Hematopoietic Stem Cell Transplantation
    Xu Guo-Fa
    Chen Ting
    Liu Huanfeng
    Lin Shijia
    Lei Gao
    Cheng Zhang
    Yao Liu
    Xi Zhang
    Zeng, Defu
    Kong Peiyan
    BLOOD, 2018, 132
  • [4] Esculetin Downregulates the Expression of AML1-ETO and C-Kit in Kasumi-1 Cell Line by Decreasing Half-Life of mRNA
    Sawney, Sharad
    Arora, Rashi
    Aggarwal, Kamal K.
    Saluja, Daman
    JOURNAL OF ONCOLOGY, 2015, 2015
  • [5] Boswellia dalzielii-Mediated Silver Nanoparticles Inhibited Acute Myeloid Leukemia (AML) Kasumi-1 Cells by Inducing Cell Cycle Arrest
    Adebayo, Ismail Abiola
    Usman, Adamu Ibrahim
    Shittu, Fatimah Bukola
    Ismail, Noor Zafirah
    Arsad, Hasni
    Muftaudeen, Taoheed Kolawole
    Samian, Mohammed Razip
    BIOINORGANIC CHEMISTRY AND APPLICATIONS, 2020, 2020
  • [6] Isolation and characterisation of Kasumi-1 human myeloid leukaemia cell line resistant to tumour necrosis factor alpha-induced apoptosis
    Ido, M
    Hayashi, K
    Kato, S
    Ogawa, H
    Komada, Y
    Zhau, YW
    Zhang, XL
    Sakurai, M
    Suzuki, K
    BRITISH JOURNAL OF CANCER, 1996, 73 (03) : 360 - 365
  • [7] Outcomes of Induction with Venetoclax in Combination with Decitabine, Azacitidine, or Low-Dose Cytarabine for Treatment of AML: A Real-World Retrospective Analysis
    Bouligny, Ian M.
    Maher, Keri R.
    BLOOD, 2021, 138
  • [8] Maintenance Treatment With Low-Dose Decitabine After Allogeneic Hematopoietic Cell Transplantation in Patients With Adult Acute Lymphoblastic Leukemia
    Liu, Jia
    Jiang, Zhong-Xing
    Xie, Xin-Sheng
    Wan, Ding-Ming
    Cao, Wei-Jie
    Wang, Meng
    Liu, Zhen-Zhen
    Dong, Zhen-Kun
    Wang, Hai-Qiong
    Lu, Run-Qing
    Zhang, Yin-Yin
    Cheng, Qian-Qian
    Fan, Ji-Xin
    Li, Wei
    He, Fei
    Guo, Rong
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [9] Induction of apoptosis by low dose cyclosporin a in a proximal tubular cell line.
    Healy, E
    Ryan, MP
    KIDNEY INTERNATIONAL, 1996, 50 (05) : 1805 - 1805
  • [10] Phase II study of low-dose decitabine for the front-line treatment of older patients with acute myeloid leukemia (AML).
    Cashen, Amanda
    Schiller, Gary J.
    Larsen, Julie S.
    Cullen, Michael T., Jr.
    DiPersio, John F.
    BLOOD, 2006, 108 (11) : 561A - 562A
12345